000 01382 a2200385 4500
005 20250514224417.0
264 0 _c20050926
008 200509s 0 0 eng d
022 _a0041-1345
024 7 _a10.1016/j.transproceed.2005.01.054
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNath, D S
245 0 0 _aFungal infections in transplant recipients receiving alemtuzumab.
_h[electronic resource]
260 _bTransplantation proceedings
_cMar 2005
300 _a934-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAlemtuzumab
650 0 4 _aAntibodies, Monoclonal
_xadverse effects
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aAntibodies, Neoplasm
_xadverse effects
650 0 4 _aGraft Rejection
_xprevention & control
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aMycoses
_xchemically induced
650 0 4 _aPancreas Transplantation
_ximmunology
650 0 4 _aPostoperative Complications
_xmicrobiology
650 0 4 _aRetrospective Studies
700 1 _aKandaswamy, R
700 1 _aGruessner, R
700 1 _aSutherland, D E R
700 1 _aDunn, D L
700 1 _aHumar, A
773 0 _tTransplantation proceedings
_gvol. 37
_gno. 2
_gp. 934-6
856 4 0 _uhttps://doi.org/10.1016/j.transproceed.2005.01.054
_zAvailable from publisher's website
999 _c15516087
_d15516087